KYMERA THERAPEUTICS, INC. (KYMR) Return on equity 2020–2025
KYMERA THERAPEUTICS, INC. (KYMR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-19.7%FY2025 · since FY2020: -16.1% → -19.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -19.7% | +7.1 pp |
| FY2024 | -26.8% | +10.4 pp |
| FY2023 | -37.2% | -5.6 pp |
| FY2022 | -31.6% | -9.8 pp |
| FY2021 | -21.8% | -5.7 pp |
| FY2020 | -16.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More KYMR financial trends
KYMR RevenueKYMR Net incomeKYMR Net marginKYMR Gross profitKYMR Gross marginKYMR Operating incomeKYMR Operating marginKYMR Operating cash flowKYMR Free cash flowKYMR Capital expendituresKYMR Stock buybacksKYMR Dividends paidKYMR Total assetsKYMR Total liabilitiesKYMR Shareholders’ equityKYMR overview →